Literature DB >> 21323726

Early induction of interleukin-5 and peripheral eosinophilia in acute pneumonia in Japanese children infected by pandemic 2009 influenza A in the Tokyo area.

Masaru Terai1, Takafumi Honda, Shiho Yamamoto, Masaki Yoshida, Nozomi Tsuchiya, Yoko Moriyama, Takuya Matsui, Shoko Tokutake, Emiyu Suzuki, Yuri Shirato, Ayako Muto, Kitami Hayashi, Hiromichi Hamada.   

Abstract

A novel influenza A (2009 H1N1) virus has led to a worldwide pandemic. A significant number of patients with pneumonia have been reported, although its pathogenesis remains to be elucidated. To determine its pathogenesis, we evaluated serum interleukin (IL)-5 and peripheral eosinophil counts in patients with acute pneumonia caused by the 2009 H1N1 virus. During the period from October to December 2009, 40 patients with laboratory-confirmed 2009 H1N1 pneumonia were under investigation. Their mean age at presentation was 6.8 years. The most characteristic finding was the early development of hypoxemic respiratory distress in the first 24 hr after the onset of fever. Bronchial mucous plugs included eosinophils in addition to neutrophils, even in patients without allergies. Serum IL-5 levels were elevated in 20 out of 24 patients (83%) whose samples were obtained in the first 24 hr after the onset of fever (26.5 ± 20.1 pg/mL), independent of the presence of underlying allergies. In contrast, induction of IL-5 was not documented in sera from eight patients with laboratory-confirmed 2009 H1N1 virus who developed neurological complications, but without lower respiratory infection (2.1 ± 0.7 pg/mL, P < 0.001 vs acute pneumonia). Peripheral eosinophilia was characteristic in acute pneumonia, but not in patients without a lower respiratory infection. There was a marked difference in the induction of IL-5 in 2009 H1N1 patients who developed acute pneumonia, compared with those without a lower respiratory infection. IL-5 may play a role in the early phase of acute pneumonia caused by the 2009 H1N1 virus in Japanese children.
© 2011 The Societies and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21323726     DOI: 10.1111/j.1348-0421.2011.00320.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  10 in total

1.  Differential pathological and immune responses in newly weaned ferrets are associated with a mild clinical outcome of pandemic 2009 H1N1 infection.

Authors:  Stephen S H Huang; David Banner; Norbert Degousee; Alberto J Leon; Louling Xu; Stephane G Paquette; Thirumagal Kanagasabai; Yuan Fang; Salvatore Rubino; Barry Rubin; David J Kelvin; Alyson A Kelvin
Journal:  J Virol       Date:  2012-10-10       Impact factor: 5.103

Review 2.  Eosinophils as Major Player in Type 2 Inflammation: Autoimmunity and Beyond.

Authors:  Marco Folci; Giacomo Ramponi; Ivan Arcari; Aurora Zumbo; Enrico Brunetta
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Expression of SCGB1C1 gene as a potential marker of susceptibility to upper respiratory tract infections in elite athletes - a pilot study.

Authors:  J Orysiak; J Malczewska-Lenczowska; M Bik-Multanowski
Journal:  Biol Sport       Date:  2016-03-06       Impact factor: 2.806

Review 4.  The Role of Innate Leukocytes during Influenza Virus Infection.

Authors:  Prem P Lamichhane; Amali E Samarasinghe
Journal:  J Immunol Res       Date:  2019-09-12       Impact factor: 4.818

5.  Expression of IL-5 receptor alpha by murine and human lung neutrophils.

Authors:  Stacey A Gorski; Monica G Lawrence; Amy Hinkelman; MarthaJoy M Spano; John W Steinke; Larry Borish; W Gerald Teague; Thomas J Braciale
Journal:  PLoS One       Date:  2019-08-15       Impact factor: 3.240

6.  Interleukin-5, interleukin-6, interferon induced protein-10, procalcitonin and C-reactive protein among mechanically ventilated severe community-acquired viral and bacterial pneumonia patients.

Authors:  Jaana Karhu; Tero Ilmari Ala-Kokko; Tytti Vuorinen; Pasi Ohtonen; Ilkka Julkunen; Hannu Tapani Syrjälä
Journal:  Cytokine       Date:  2018-07-25       Impact factor: 3.861

7.  Type I interferon restricts type 2 immunopathology through the regulation of group 2 innate lymphoid cells.

Authors:  Claudia U Duerr; Connor D A McCarthy; Barbara C Mindt; Manuel Rubio; Alexandre P Meli; Julien Pothlichet; Megan M Eva; Jean-François Gauchat; Salman T Qureshi; Bruce D Mazer; Karen L Mossman; Danielle Malo; Ana M Gamero; Silvia M Vidal; Irah L King; Marika Sarfati; Jörg H Fritz
Journal:  Nat Immunol       Date:  2015-11-23       Impact factor: 31.250

8.  Group 2 innate lymphoid cell production of IL-5 is regulated by NKT cells during influenza virus infection.

Authors:  Stacey Ann Gorski; Young S Hahn; Thomas J Braciale
Journal:  PLoS Pathog       Date:  2013-09-19       Impact factor: 6.823

9.  Eosinophilic Gastrointestinal Disorder Presenting as Intractable Vomiting and Ascites in a Young Girl.

Authors:  Ji Yoon Kwon; Ji Sun Huh; Bo Kyung Je; Kwang Dae Hong; Jee Hyun Lee
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2017-09-26

Review 10.  Influenza in Asthmatics: For Better or for Worse?

Authors:  Raja Veerapandian; John D Snyder; Amali E Samarasinghe
Journal:  Front Immunol       Date:  2018-08-10       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.